Developing and Pre-Testing an eHealth Group Intervention for Young Adult Cancer Survivors

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

6 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-09-01

Study Completion Date

2021-12-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to develop and pre-test an eHealth group intervention for young adult cancer survivors.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Study to Develop a Group-Based E-Health Intervention for YA Cancer Survivors

NCT05048316

Cancer Survivor Young Adult

COMPLETED NA

Digital Connections: an EHealth Group Intervention for Young Adult Cancer Survivors

NCT05952492

Cancer

COMPLETED NA

E-health Intervention for Cancer Survivors

NCT01114802

Cancer

COMPLETED PHASE1

mHealth for Young Adult Cancer Survivors

NCT05905250

Survivorship Cancer Psychological Well-Being

COMPLETED NA

E-health Intervention for Cancer Survivors 2.0

NCT01348997

Cancer

WITHDRAWN PHASE1

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In the first part of this study, the investigators adapted an evidence-based intervention for improving HRQOL to better meet the needs of young adult cancer survivors, and then conducted focus groups with young adult cancer survivors to get feedback on the adapted intervention. In the second part of the study, the investigators will conduct a single-arm pilot trial in which the adapted intervention will be delivered over videoconference via weekly group meetings with a trained facilitator over the course of 10 weeks.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

10-week eHealth intervention

Weekly video conference groups led by a trained facilitator

Group Type EXPERIMENTAL

Cognitive-Behavioral Stress Management and Health Education

Intervention Type BEHAVIORAL

Participants will attend group sessions with a trained facilitator held over videoconference. Sessions will each last 2 hours and will be held once weekly for 10 weeks. Sessions will include Cognitive-Behavioral Stress Management and health education content.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Cognitive-Behavioral Stress Management and Health Education

Participants will attend group sessions with a trained facilitator held over videoconference. Sessions will each last 2 hours and will be held once weekly for 10 weeks. Sessions will include Cognitive-Behavioral Stress Management and health education content.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* age 18-39 years at the time of participation
* diagnosed with a non-metastatic primary cancer between 18-39 years old
* completed primary cancer treatment (excepting hormone therapy) 1 month to 5 years prior to enrollment
* able to speak and read English
* access to internet or cellular connectivity with sufficient bandwidth to participate in videoconferences

Exclusion Criteria

* metastatic disease
* psychiatric or neurological disorders that could interfere with study participation
* considered part of a vulnerable population

Minimum Eligible Age

18 Years

Maximum Eligible Age

39 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No